Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
Clinical and Molecular Hepatology · 01.10.2023 · 29 (4) · 945-957
DOI: 10.3350/cmh.2023.0217 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.10.2023. Verfasst von Hwa Kyung Byun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Heavy Ion Radiotherapy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a highly lethal cancer with limited treatment options and poor prognosis. Carbon ion radiotherapy (CIRT) has emerged as a promising treatment modality for HCC due to its unique physical and biological properties. CIRT uses carbon ions to target and destroy cancer cells with a high precision and efficacy. The Bragg Peak phenomenon allows precise dose delivery to the tumor while minimizing damage to healthy tissues. In addition, the high relative biological effectiveness of carbon ions can be shown against radioresistant and hypoxic tumor areas. CIRT also offers a shorter treatment schedule than conventional radiotherapy, which increases patient convenience and compliance. The clinical outcomes of CIRT for HCC have shown excellent local control rates with minimal side effects. Considering its physical and biological properties, CIRT may be a viable option for complex clinical scenarios such as patients with poor liver function, large tumors, re-irradiation cases, and tumors close to critical organs. Further research and larger studies are needed to establish definitive indications for CIRT and to compare its efficacy with that of other treatment modalities. Nevertheless, CIRT offers a potential breakthrough in HCC management, providing hope for improved therapeutic outcomes and reduced treatment-related toxicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Zitieren
APA
Byun, H. K., Kim, C., & Seong, J. (2023). Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma. Clinical and Molecular Hepatology, 29(4), 945-957. https://doi.org/10.3350/cmh.2023.0217
Vancouver
Byun HK, Kim C, Seong J. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma. Clinical and Molecular Hepatology. 2023;29(4):945-957. doi:10.3350/cmh.2023.0217
BibTeX
@article{Byun2023,
author = {Byun, Hwa Kyung and Kim, Changhwan and Seong, Jinsil},
title = {Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma},
journal = {Clinical and Molecular Hepatology},
year = {2023},
volume = {29},
number = {4},
pages = {945--957},
doi = {10.3350/cmh.2023.0217}
}
EUVIMED